NGNM.OB Insider Trading Activity and SEC Form 4 Filings
NGNM.OB insider trading summary
No open-market insider purchases or sales of Neogenomics Inc (NGNM.OB) have been reported on SEC Form 4 in the past 12 months.
Latest NGNM.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 20, 2012 | Aspen Select Healthcare LP | Executive VP of Finance | Sell | $3K (1,100 @ $2.75) |
| Dec 20, 2012 | Steven C Jones | Executive VP of Finance | Sell | $3K (1,100 @ $2.75) |
| Dec 19, 2012 | Aspen Select Healthcare LP | Executive VP of Finance | Sell | $23K (8,225 @ $2.75) |
| Dec 19, 2012 | Steven C Jones | Executive VP of Finance | Sell | $23K (8,225 @ $2.75) |
| Dec 18, 2012 | Steven C Jones | Executive VP of Finance | Sell | $1.7M (632,114 @ $2.75) |
| Dec 18, 2012 | Aspen Select Healthcare LP | Executive VP of Finance | Sell | $1.7M (632,114 @ $2.75) |
| Sep 28, 2012 | Michael T Dent | Director | Sell | $226K (75,000 @ $3.01) |
| Sep 28, 2012 | Steven C Jones | Executive VP of Finance | Sell | $12K (4,000 @ $3.02) |
| Sep 28, 2012 | Aspen Select Healthcare LP | Executive VP of Finance | Sell | $12K (4,000 @ $3.02) |
| Sep 28, 2012 | Steven C Jones | Executive VP of Finance | Sell | $96K (31,800 @ $3.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.